Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

593 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The impact of granulocyte colony stimulating factor on patients receiving chimeric antigen receptor T-cell therapy.
Barreto JN, Bansal R, Hathcock MA, Doleski CJ, Hayne JR, Truong TA, Nedved AN, Ansell SM, Bennani NN, Paludo J, Villasboas JC, Lin Y, Johnston PB. Barreto JN, et al. Among authors: ansell sm. Am J Hematol. 2021 Oct 1;96(10):E399-E402. doi: 10.1002/ajh.26313. Epub 2021 Aug 14. Am J Hematol. 2021. PMID: 34350612 Free article. No abstract available.
Epstein-Barr virus infection in Richter's transformation.
Ansell SM, Li CY, Lloyd RV, Phyliky RL. Ansell SM, et al. Am J Hematol. 1999 Feb;60(2):99-104. doi: 10.1002/(sici)1096-8652(199902)60:2<99::aid-ajh3>3.0.co;2-t. Am J Hematol. 1999. PMID: 9929100 Free article.
CD34+ cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before allogeneic hematopoietic SCT for hematologic malignancies.
Holtan SG, Hogan WJ, Elliott MA, Ansell SM, Inwards DJ, Porrata LF, Johnston PB, Micallef IN, Lacy MQ, Gastineau DA, Litzow MR. Holtan SG, et al. Among authors: ansell sm. Bone Marrow Transplant. 2010 Dec;45(12):1699-703. doi: 10.1038/bmt.2010.49. Epub 2010 Mar 8. Bone Marrow Transplant. 2010. PMID: 20208572 Free PMC article.
Low risk of symptomatic venous thromboembolic events during growth factor administration for PBSC mobilization.
Naina HV, Pruthi RK, Inwards DJ, Dingli D, Litzow MR, Ansell SM, William HJ, Dispenzieri A, Buadi FK, Elliott MA, Gastineau DA, Gertz MA, Hayman SR, Johnston PB, Lacy MQ, Micallef IN, Porrata LF, Kumar S. Naina HV, et al. Among authors: ansell sm. Bone Marrow Transplant. 2011 Feb;46(2):291-3. doi: 10.1038/bmt.2010.106. Epub 2010 May 3. Bone Marrow Transplant. 2011. PMID: 20436522
Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma.
Porrata LF, Rsitow K, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Habermann TM, Witzig TE, Colgan JP, Nowakowski GS, Thompson CA, Markovic SN. Porrata LF, et al. Among authors: ansell sm. Leukemia. 2010 Jul;24(7):1343-9. doi: 10.1038/leu.2010.108. Epub 2010 May 20. Leukemia. 2010. PMID: 20485372
Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early intervention.
Sinha S, Gastineau D, Micallef I, Hogan W, Ansell S, Buadi F, Dingli D, Dispenzieri A, Gertz M, Greiner C, Hayman S, Inwards D, Johnston P, Lacy M, Litzow M, Porrata L, Winters JL, Kumar S. Sinha S, et al. Bone Marrow Transplant. 2011 Jul;46(7):943-9. doi: 10.1038/bmt.2010.236. Epub 2010 Oct 11. Bone Marrow Transplant. 2011. PMID: 20935680 Free PMC article.
A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma.
Witzig TE, Reeder CB, LaPlant BR, Gupta M, Johnston PB, Micallef IN, Porrata LF, Ansell SM, Colgan JP, Jacobsen ED, Ghobrial IM, Habermann TM. Witzig TE, et al. Among authors: ansell sm. Leukemia. 2011 Feb;25(2):341-7. doi: 10.1038/leu.2010.226. Epub 2010 Dec 7. Leukemia. 2011. PMID: 21135857 Free PMC article. Clinical Trial.
593 results